Aminophyllin and Shock - a phase IV clinical study of FDA data

Summary:

Shock is reported as a side effect among people who take Aminophyllin (aminophylline), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Indomethacin, and have Asthma.

The phase IV clinical study analyzes which people have Shock when taking Aminophyllin. It is created by eHealthMe based on reports of 3,088 people who have side effects when taking Aminophyllin from the FDA, and is updated regularly.

What is Aminophyllin?

Aminophyllin has active ingredients of aminophylline. eHealthMe is studying from 3,118 Aminophyllin users. Check the latest studies of Aminophyllin.

What is Shock?

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin) is found to be associated with 1,218 drugs and 1,753 conditions by eHealthMe. Check the latest studies of Shock.

On Jul, 15, 2026

3,088 people reported to have side effects when taking Aminophyllin.
Among them, 19 people (0.62%) have Shock.

Among these 19 people:

How long have people been on Aminophyllin when they have Shock? *

What is the gender of people who have Shock when taking Aminophyllin? *

female: 78.95 %
male: 21.05 %

What is the age of people who have Shock when taking Aminophyllin? *

What are other drugs people take besides Aminophyllin? *

What are other side effects people have besides Shock? *

Pneumatosis Intestinalis (air or gas in an intestine): 5 people, 26.32%
Necrotising Enterocolitis Neonatal (life threatening infection of intestine in newborn baby): 5 people, 26.32%
Acidosis (build-up of carbon dioxide in the blood): 5 people, 26.32%
Hypotension (abnormally low blood pressure): 5 people, 26.32%
Dyspnea (difficult or laboured breathing): 5 people, 26.32%
Fever: 5 people, 26.32%
Arrhythmias (irregular heartbeat): 5 people, 26.32%
Pneumonia: 4 people, 21.05%
C-Reactive Protein Increased: 4 people, 21.05%
Urine Output - Decreased: 4 people, 21.05%

What are the existing conditions these people have? *

Asthma: 6 people, 31.58%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 15.79%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.53%
Cardiac Failure: 2 people, 10.53%
Osteoporosis (bones weak and more likely to break): 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 5.26%
Cellulitis (infection under the skin): 1 person, 5.26%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Aminophyllin and have Shock?

- Check whether Shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aminophyllin:

Aminophyllin (3,118 reports)

Shock treatments and more:

Shock (28,534 reports)

Browse all side effects of Aminophyllin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Shock:

Shock (1,218 drugs)

Browse all the conditions that are associated with Shock:

Shock (1,753 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminophylline (the active ingredients of Aminophyllin) and Aminophyllin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.